Global Glucagon Market By Type (Inject Glucagon, Nasal Glucagon), By Application (Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock and Others) and By Regions - Global Forecast 2030

“Global Glucagon Market” is the title of a recently published market report compiled by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global glucagon market has been segmented on the basis of type, application, as well as regions and countries.

The Global Glucagon Market was valued at UЅD $487.6 Мn in 2020, and is projected to achieve a valuation of UЅD $837 Мn by 2030, at a САGR of 6.6%.

Overview:

Glucagon is a peptide hormone, produced by alpha cells of the pancreas. It works to raise the concentration of glucose and fatty acids in the bloodstream, and is considered to be the primary catabolic hormone of the body.

Dynamics:

Numerous advancements in the administration of non-injectable emergency glucagon, as well as the steady increase in the prevalence of hypoglycemia among individuals suffering from diabetes are some of the primary factors that are expected to continue to fuel the revenue growth of the global glucagon market over the next 10 years. Moreover, the increase in approvals for new products by respective governing bodies, and the steady elevation of awareness levels concerning the uses and benefits of this product are also factors that are slated to influence market growth for this global industry in the coming years.

Additionally, the steady expansion of geriatric populations across the world is another major factor that is expected to continue to boost revenue growth opportunities for the global glucagon market in the foreseeable future, as these individuals are more susceptible to developing chronic diseases and other disorders that would require the aid of products from this industry.

However, in light of the recent COVID-19 outbreak, the operations of numerous industries have either been temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global glucagon market is no different, and this factor is anticipated to have a negative impact on the revenue growth of this industry. Furthermore, the high cost of glucagon is another factor that may impede on the market growth of this global industry.

Nonetheless, numerous initiatives and increasing investments are being focused by key industry players towards the development of improved forms of treatment, as well as to make diabetes-related expenditures more economical, are some of the other factors that are expected to further augment future market growth for the global glucagon industry.

Segmentation of the Global Glucagon Market is as follows:

In terms of product type, the kits segment accounted for the maximum number of revenue shares of the global glucagon market in 2020, and is expected to index a high CAGR over the forecast period. However, the powder/solution segment is anticipated to index the highest CAGR over the next 10 years.

With regards to application, the emergency use segment accounted for the highest number of revenue shares of the global glucagon market in 2020, and is anticipated to continue doing so over the next decade. The general use segment is also indicative of registering a high CAGR over the forecast period.

Regional Segmentation and Analysis:

North America accounted for the maximum number of revenue shares of the global glucagon market in 2020, and is indicative of remaining this industry’s front-runner over the next decade. However, the markets in the Asia pacific region are anticipated to index the highest CAGR over the course of the forecast period.

Segmentation of the Global Glucagon Market:

Segmentation by Type:

• Inject Glucagon
• Nasal Glucagon

Segmentation by Application:

• Emergency Kits
• General Use
• Diagnostic & Motility
• Cardiogenic Shock
• Others

Segmentation by Regions:

• North America
• Europe
• APAC
• Latin America
• MEA